Duygu Ozol
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Duygu Ozol has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Büşra Durak
Department of Chest Disease, Çorum Hitit University Faculty of Medicine, Corum, Türkiye
3 shared publications Harun Karamanlı
Department of Respiratory Medicine, Fatih University Medical School, Ankara, Turkey
3 shared publications- Sema Saraç
Department of Chest Diseases, University of Health Sciences, Sureyyapasa Training and Research Hospital, İstanbul, Türkiye
3 shared publications Zeki Yıldırım
Fatih University Medical School
3 shared publicationsEmin Mete
Fatih University Faculty Of Medicine
2 shared publicationsMikdat Bozer
Fatih University
2 shared publications
Latest Publications
- Open Access
- 23 February 2026
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 37 (5) , 590-597
Nocturnal Melatonin Deficiency in Colorectal Cancer: Independent Predictive Value Beyond Sleep Quality
Background/Aim: Melatonin is a cytoprotective hormone with antioxidant activity and also mediates regulatory effects that inhibit tumor proliferation and angiogenesis. This study aimed to evaluate serum melatonin levels and sleep quality in patients with newly diagnosed colorectal cancer (CRC) compared with controls and to investigate whether melatonin could serve as a potential biomarker. Materials and Methods: A total of 71 participants (36 CRC, 35 controls) were included. Blood samples were obtained between 01:00- 02:00 am and serum melatonin was measured using a high-sensitivity (ELISA) Enzyme-Linked Immunosorbent Assay kit. Sleep quality was assessed with the Pittsburgh Sleep Quality Index (PSQI) and sleep apnea risk was determined by the STOP-Bang questionnaire. Group comparisons were performed, followed by multivariable logistic regression and receiver-operating characteristic analysis. Results: Colorectal cancer patients had significantly lower nocturnal serum melatonin concentrations (131.1 Å} 35.5 vs. 194.8 Å} 50.8 pg/ mL, P < .001) and higher PSQI scores (5.6 Å} 3.1 vs. 5.1 Å} 3.0, P = .028). In multivariable analysis, melatonin remained the only independent predictor of CRC (OR = 0.952, 95% CI: 0.929-0.976, P < .001). Receiver-operating characteristic analysis identified a melatonin threshold of ~150 pg/mL, discriminating CRC patients from controls with 75% sensitivity and 91.4% specificity (AUC = 0.877). Conclusion: Although cancer patients and the control group showed comparable obstructive sleep apnea risk, sleep quality was poorer, and melatonin levels were significantly lower in the cancer group. Melatonin assessment can complement traditional risk stratification and may provide new insights into the interplay between circadian biology, sleep, and colorectal carcinogenesis. Cite this article as: Durak I, Durak B, Duzenli T, et al. Nocturnal melatonin deficiency in colorectal cancer: independent predictive value beyond sleep quality. Turk J Gastroenterol. Published online February 23, 2026. doi: 10.5152/tjg.2026.25808.
- 23 February 2026
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 37 (5) , 590-597
Open AccessNocturnal Melatonin Deficiency in Colorectal Cancer: Independent Predictive Value Beyond Sleep Quality
Background/Aim: Melatonin is a cytoprotective hormone with antioxidant activity and also mediates regulatory effects that inhibit tumor proliferation and angiogenesis. This study aimed to evaluate serum melatonin levels and sleep quality in patients with newly diagnosed colorectal cancer (CRC) compared with controls and to investigate whether melatonin could serve as a potential biomarker. Materials and Methods: A total of 71 participants (36 CRC, 35 controls) were included. Blood samples were obtained between 01:00- 02:00 am and serum melatonin was measured using a high-sensitivity (ELISA) Enzyme-Linked Immunosorbent Assay kit. Sleep quality was assessed with the Pittsburgh Sleep Quality Index (PSQI) and sleep apnea risk was determined by the STOP-Bang questionnaire. Group comparisons were performed, followed by multivariable logistic regression and receiver-operating characteristic analysis. Results: Colorectal cancer patients had significantly lower nocturnal serum melatonin concentrations (131.1 Å} 35.5 vs. 194.8 Å} 50.8 pg/ mL, P < .001) and higher PSQI scores (5.6 Å} 3.1 vs. 5.1 Å} 3.0, P = .028). In multivariable analysis, melatonin remained the only independent predictor of CRC (OR = 0.952, 95% CI: 0.929-0.976, P < .001). Receiver-operating characteristic analysis identified a melatonin threshold of ~150 pg/mL, discriminating CRC patients from controls with 75% sensitivity and 91.4% specificity (AUC = 0.877). Conclusion: Although cancer patients and the control group showed comparable obstructive sleep apnea risk, sleep quality was poorer, and melatonin levels were significantly lower in the cancer group. Melatonin assessment can complement traditional risk stratification and may provide new insights into the interplay between circadian biology, sleep, and colorectal carcinogenesis. Cite this article as: Durak I, Durak B, Duzenli T, et al. Nocturnal melatonin deficiency in colorectal cancer: independent predictive value beyond sleep quality. Turk J Gastroenterol. Published online February 23, 2026. doi: 10.5152/tjg.2026.25808.
- Open Access
- 1 January 2026
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 30 (3) , 184-189
The Hidden Burden of COMISA in Hypertensive Obstructive Sleep Apnea Patients
The Anatolian Journal of Cardiology - Peer-reviewed cardiology journal publishing original research, reviews, case reports. Impact Factor 1.5. The Anatolian Journal of Cardiology - Leading international cardiology journal with Impact Factor 1.5. Publishing original research, reviews, and case reports in cardiovascular medicine. Indexed in PubMed, Scopus, and Web of Science.
- 1 January 2026
- Published by Kare Publishing in The Anatolian Journal of Cardiology
- Vol. 30 (3) , 184-189
Open AccessThe Hidden Burden of COMISA in Hypertensive Obstructive Sleep Apnea Patients
The Anatolian Journal of Cardiology - Peer-reviewed cardiology journal publishing original research, reviews, case reports. Impact Factor 1.5. The Anatolian Journal of Cardiology - Leading international cardiology journal with Impact Factor 1.5. Publishing original research, reviews, and case reports in cardiovascular medicine. Indexed in PubMed, Scopus, and Web of Science.
- 17 October 2025
- Published by Springer Nature in Sleep and Breathing
- Vol. 29 (6) , 1-8
Sleep and neurocognitive function in the geriatric population: a cross-sectional comparison between nursing-home and community-dwelling older adults
Purpose This study aimed to evaluate the effects of institutional care on sleep quality, cognitive functions, and quality of life in individuals aged 65 and over living in Türkiye. Methods This cross-sectional study included a total of 62 elderly individuals, either residing in a nursing home or living in their own homes. Participants were assessed using the Pittsburgh Sleep Quality Index (PSQI), Mini-Mental State Examination (MMSE), and WHO-5 Well-Being Index. After adjusting for age and education, ANCOVA confirmed that nursing home residents had significantly lower MMSE scores than community-dwelling individuals (F(1,58)=7.98, p=0.006, partial η²=0.121). Results The mean PSQI score of the participants was 8.06± 3.3, and 64.5% had a score ≥5, indicating poor sleep quality overall. The MMSE scores were significantly lower in nursing home residents compared to community-dwelling individuals (22.2 ± 4.4 vs. 25.2 ± 3.4; p = 0.005). These differences in MMSE remained significant after adjustment for age and education (ANCOVA, p=0.006). Sleep latency was shorter (p = 0.022) and daytime dysfunction was higher (p = 0.028) among nursing home residents, while sleep efficiency was significantly better in those living at home (p = 0.030). A weak but statistically significant negative weak correlation was found between PSQI and WHO-5 scores (r = –0.299, 95% CI: –0.51 to –0.05, p = 0.018). However, no significant correlation was observed between PSQI and MMSE scores. Conclusions Nursing-home residents exhibited lower cognitive performance and poorer sleep efficiency compared to community dwellers, reflecting group differences.
- 17 October 2025
- Published by Springer Nature in Sleep and Breathing
- Vol. 29 (6) , 1-8
Sleep and neurocognitive function in the geriatric population: a cross-sectional comparison between nursing-home and community-dwelling older adults
Purpose This study aimed to evaluate the effects of institutional care on sleep quality, cognitive functions, and quality of life in individuals aged 65 and over living in Türkiye. Methods This cross-sectional study included a total of 62 elderly individuals, either residing in a nursing home or living in their own homes. Participants were assessed using the Pittsburgh Sleep Quality Index (PSQI), Mini-Mental State Examination (MMSE), and WHO-5 Well-Being Index. After adjusting for age and education, ANCOVA confirmed that nursing home residents had significantly lower MMSE scores than community-dwelling individuals (F(1,58)=7.98, p=0.006, partial η²=0.121). Results The mean PSQI score of the participants was 8.06± 3.3, and 64.5% had a score ≥5, indicating poor sleep quality overall. The MMSE scores were significantly lower in nursing home residents compared to community-dwelling individuals (22.2 ± 4.4 vs. 25.2 ± 3.4; p = 0.005). These differences in MMSE remained significant after adjustment for age and education (ANCOVA, p=0.006). Sleep latency was shorter (p = 0.022) and daytime dysfunction was higher (p = 0.028) among nursing home residents, while sleep efficiency was significantly better in those living at home (p = 0.030). A weak but statistically significant negative weak correlation was found between PSQI and WHO-5 scores (r = –0.299, 95% CI: –0.51 to –0.05, p = 0.018). However, no significant correlation was observed between PSQI and MMSE scores. Conclusions Nursing-home residents exhibited lower cognitive performance and poorer sleep efficiency compared to community dwellers, reflecting group differences.
- 7 October 2025
- Published by Springer Nature in Sleep and Breathing
- Vol. 29 (5) , 1-8
Determinants of MSLT- defined sleepiness in OSA patients with neuropsycological findings
Purpose Obstructive sleep apnea (OSA) is a common breathing disease charecterized by excessive daytime sleepiness (EDS) as a main symptom. Our aim in this study was to identify the determinants of EDS detected by multiple sleep latency test (MSLT) in OSA patients and to investigate its relationship with neuropsycological functions. Methods In this prospective study, for a3 months period all participants underwent overnight polysomnography (PSG) followed by MSLT, conducted according to American Academy of Sleep Medicine (AASM) guidelines. EDS was defined as MSLT score < 8 min, while severe EDS was considered as < 5 min. Neurocognitive function and depressive symptoms were assessed using questionaires. Results A total of 82 patients (mean age: 50.1 ± 14 years, 34 females, 41.5%) were included. The minumum oxygen value and oxygen desaturation index (ODI) were detected as the main indicators of MSLT-linked EDS in multivariate analysis. It was determined that each increase in ODI value increased EDS by 1.03 times, while an increase in oxygen level caused a 0.89-fold decrease in EDS. According to the Mini Mental Test (MMT) and Beck Depresion Inventory (BDI) results, a total of 33 (40.2%) of the patients had mild, 7 (8.5%) had moderate neurocognitive disfunctions and 30 (38%) had depression with no relationship with MSLT-linked EDS when threshold of 8 min was used. However, in the severely sleepy group, the MMT score began to show a significant decline. Conclusion EDS was more stroıngly associated with hypoxic burden than with Apnea hypopnea index (AHI). Although neurocognitive impairement and depression was high in OSA, this was relevant only with severely sleepy group.
- 7 October 2025
- Published by Springer Nature in Sleep and Breathing
- Vol. 29 (5) , 1-8
Determinants of MSLT- defined sleepiness in OSA patients with neuropsycological findings
Purpose Obstructive sleep apnea (OSA) is a common breathing disease charecterized by excessive daytime sleepiness (EDS) as a main symptom. Our aim in this study was to identify the determinants of EDS detected by multiple sleep latency test (MSLT) in OSA patients and to investigate its relationship with neuropsycological functions. Methods In this prospective study, for a3 months period all participants underwent overnight polysomnography (PSG) followed by MSLT, conducted according to American Academy of Sleep Medicine (AASM) guidelines. EDS was defined as MSLT score < 8 min, while severe EDS was considered as < 5 min. Neurocognitive function and depressive symptoms were assessed using questionaires. Results A total of 82 patients (mean age: 50.1 ± 14 years, 34 females, 41.5%) were included. The minumum oxygen value and oxygen desaturation index (ODI) were detected as the main indicators of MSLT-linked EDS in multivariate analysis. It was determined that each increase in ODI value increased EDS by 1.03 times, while an increase in oxygen level caused a 0.89-fold decrease in EDS. According to the Mini Mental Test (MMT) and Beck Depresion Inventory (BDI) results, a total of 33 (40.2%) of the patients had mild, 7 (8.5%) had moderate neurocognitive disfunctions and 30 (38%) had depression with no relationship with MSLT-linked EDS when threshold of 8 min was used. However, in the severely sleepy group, the MMT score began to show a significant decline. Conclusion EDS was more stroıngly associated with hypoxic burden than with Apnea hypopnea index (AHI). Although neurocognitive impairement and depression was high in OSA, this was relevant only with severely sleepy group.
- 1 January 2014
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 44 (5) , 804-808
Airway inflammation and tiotropium treatment in stable COPD patients
Background/aim: Chronic obstructive pulmonary disease (COPD) is an inflammatory disease of the lung associated with progressive airflow limitation. The aim of this study is to assess the influence of tiotropium treatment on airway inflammation and symptoms in stable COPD patients. Materials and methods: Inflammatory markers were measured in the expired breath condensate fluid (EBC) before starting tiotropium treatment and at the end of the first month. Results: Twenty-two patients (81% men). with a mean age of 65.4 +/- 10.1 years completed the study. The mean nitrotyrosine and 8-isoprostane levels for oxidative stress markers in EBC before and after treatment were 4.5 +/- 2.3, 3.5 +/- 1.9 pg/mL (P = 0.06) and 7.3 +/- 10.8, 8.1 +/- 11.7 pg/mL (P = 0.28), respectively. The mean interleukin-6 and tumor necrosis factor-alpha levels for inflammation markers in EBC before and after treatment were 1.03 +/- 1.1, 0.77 +/- 0.8 pg/mL (P = 0.41) and 27.8 +/- 2.6, 29.2 +/- 5.7 pg/mL (P = 0.36) respectively. The mean symptom scores decreased significantly with tiotropium and a mean increase of 124.6 +/- 0.86 mL was observed in a lung function test (FEV1). Conclusion: Although a 4-week treatment with tiotropium did not modify any of the inflammatory or oxidative stress markers in EBC fluid, tiotropium treatment helps to control symptoms in COPD.
- 1 January 2014
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 44 (5) , 804-808
Airway inflammation and tiotropium treatment in stable COPD patients
Background/aim: Chronic obstructive pulmonary disease (COPD) is an inflammatory disease of the lung associated with progressive airflow limitation. The aim of this study is to assess the influence of tiotropium treatment on airway inflammation and symptoms in stable COPD patients. Materials and methods: Inflammatory markers were measured in the expired breath condensate fluid (EBC) before starting tiotropium treatment and at the end of the first month. Results: Twenty-two patients (81% men). with a mean age of 65.4 +/- 10.1 years completed the study. The mean nitrotyrosine and 8-isoprostane levels for oxidative stress markers in EBC before and after treatment were 4.5 +/- 2.3, 3.5 +/- 1.9 pg/mL (P = 0.06) and 7.3 +/- 10.8, 8.1 +/- 11.7 pg/mL (P = 0.28), respectively. The mean interleukin-6 and tumor necrosis factor-alpha levels for inflammation markers in EBC before and after treatment were 1.03 +/- 1.1, 0.77 +/- 0.8 pg/mL (P = 0.41) and 27.8 +/- 2.6, 29.2 +/- 5.7 pg/mL (P = 0.36) respectively. The mean symptom scores decreased significantly with tiotropium and a mean increase of 124.6 +/- 0.86 mL was observed in a lung function test (FEV1). Conclusion: Although a 4-week treatment with tiotropium did not modify any of the inflammatory or oxidative stress markers in EBC fluid, tiotropium treatment helps to control symptoms in COPD.
- 4 September 2012
- Published by Springer Nature in Sleep and Breathing
- Vol. 18 (2) , 251-256
Influence of CPAP treatment on airway and systemic inflammation in OSAS patients
Obstructive sleep apnea syndrome (OSAS) is characterized by recurrent respiratory disorders in the upper airways during sleep. Although continuous positive airway pressure (CPAP) has been accepted to be the most effective treatment for OSAS, its role on inflammation remains debatable. In this study, our aim was to examine the influence of 3 months of CPAP treatment on tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), 8-isoprostane, and peroxynitrite levels in exhaled breathing condensates (EBC) and serum. Thirty-five patients who were newly diagnosed as moderate or severe OSAS with full night polysomnography and used CPAP therapy regularly for 3 months were included in the study. Polysomnography, spirometric tests, fasting blood samples, and EBC were ascertained on entry into the study and after 3 months of treatment. All patients were assessed monthly for treatment adherence and side effects. We found that all polysomnographic parameters were normalized after CPAP therapy in the control polysomnogram. Also, all markers in EBC and nitrotyrosine and 8-isoprostane levels in serum were decreased significantly with CPAP treatment. Sedimentation rate, C-reactive protein, IL-6, and TNF-α remained unchanged in serum after treatment. We found that baseline nitrotyrosine levels were significantly correlated with apnea–hypopnea index, oxygen desaturation index, and percent time in SpO2 < 90 % (p < 0.01). CPAP therapy has primarily a relevant impact on airways, and nitrotyrosine levels correlated well with severity of OSAS. This treatment decreases both inflammation and oxidative stress levels in airways in OSAS patients. Also, this treatment helps to decrease systemic oxidative stress levels in serum.
- 4 September 2012
- Published by Springer Nature in Sleep and Breathing
- Vol. 18 (2) , 251-256
Influence of CPAP treatment on airway and systemic inflammation in OSAS patients
Obstructive sleep apnea syndrome (OSAS) is characterized by recurrent respiratory disorders in the upper airways during sleep. Although continuous positive airway pressure (CPAP) has been accepted to be the most effective treatment for OSAS, its role on inflammation remains debatable. In this study, our aim was to examine the influence of 3 months of CPAP treatment on tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), 8-isoprostane, and peroxynitrite levels in exhaled breathing condensates (EBC) and serum. Thirty-five patients who were newly diagnosed as moderate or severe OSAS with full night polysomnography and used CPAP therapy regularly for 3 months were included in the study. Polysomnography, spirometric tests, fasting blood samples, and EBC were ascertained on entry into the study and after 3 months of treatment. All patients were assessed monthly for treatment adherence and side effects. We found that all polysomnographic parameters were normalized after CPAP therapy in the control polysomnogram. Also, all markers in EBC and nitrotyrosine and 8-isoprostane levels in serum were decreased significantly with CPAP treatment. Sedimentation rate, C-reactive protein, IL-6, and TNF-α remained unchanged in serum after treatment. We found that baseline nitrotyrosine levels were significantly correlated with apnea–hypopnea index, oxygen desaturation index, and percent time in SpO2 < 90 % (p < 0.01). CPAP therapy has primarily a relevant impact on airways, and nitrotyrosine levels correlated well with severity of OSAS. This treatment decreases both inflammation and oxidative stress levels in airways in OSAS patients. Also, this treatment helps to decrease systemic oxidative stress levels in serum.
- 1 February 2011
- Published by SAGE Publications in Metabolic Syndrome and Related Disorders
- Vol. 9 (1) , 13-18
Relationship Between Components of Metabolic Syndrome and Polysomnographic Findings in Obstructive Sleep Apnea
Aims: Obstructive sleep apnea/hypoapnea syndrome (OSAHS) and metabolic syndrome are both growing health concerns, owing to the worldwide obesity epidemic. This study evaluates the potential association between the parameters of metabolic syndrome and OSAHS. Methods: A total of 125 consecutive patients undergoing complete full night polysomnography were included. Insulin resistance (IR) was estimated using the homeostasis model assessment (HOMA), and metabolic syndrme was diagnosed according to the National Cholesterol Education Program (NCEP) criteria. Results: The prevelance of metabolic syndrome was 23.8% among patients with OSAHS. We found that IR, age, weight, hypertension, and metabolic syndrome prevalence increased significantly with severity of OSAHS. There were no differences between groups for lipid panels including total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). Subjects with metabolic syndrome had significantly lowest desaturation value (76% vs. 81%) desaturation (76% vs. 81%, P = 0.003), lower mean nocturnal oxygen saturation (89.9% vs. 92.3%, P < 0.00.1), higher apnea–hypopnea index (AHI) (40.9 vs. 17, P < 0.001), and higher oxygen desaturation index (38 vs. 17, P = 0.002). Lowest desaturation and mean nocturnal oxygen saturation were significantly lower in subjects with IR (76% vs. 85%, P = 0.004 and 90.4% vs. 93.0%, P = 0.02). In multivariate analysis, the percent of time below 90% saturation [%T < 90]) (P = 0.04) was independently associated with IR. Conclusions: Our results suggested that metabolic syndrome prevalence increased with severity of OSAHS and vice versa. Nocturnal hypoxic episodes in OSAHS patients could be a risk factor for developing hypertension and IR.
- 1 February 2011
- Published by SAGE Publications in Metabolic Syndrome and Related Disorders
- Vol. 9 (1) , 13-18
Relationship Between Components of Metabolic Syndrome and Polysomnographic Findings in Obstructive Sleep Apnea
Aims: Obstructive sleep apnea/hypoapnea syndrome (OSAHS) and metabolic syndrome are both growing health concerns, owing to the worldwide obesity epidemic. This study evaluates the potential association between the parameters of metabolic syndrome and OSAHS. Methods: A total of 125 consecutive patients undergoing complete full night polysomnography were included. Insulin resistance (IR) was estimated using the homeostasis model assessment (HOMA), and metabolic syndrme was diagnosed according to the National Cholesterol Education Program (NCEP) criteria. Results: The prevelance of metabolic syndrome was 23.8% among patients with OSAHS. We found that IR, age, weight, hypertension, and metabolic syndrome prevalence increased significantly with severity of OSAHS. There were no differences between groups for lipid panels including total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). Subjects with metabolic syndrome had significantly lowest desaturation value (76% vs. 81%) desaturation (76% vs. 81%, P = 0.003), lower mean nocturnal oxygen saturation (89.9% vs. 92.3%, P < 0.00.1), higher apnea–hypopnea index (AHI) (40.9 vs. 17, P < 0.001), and higher oxygen desaturation index (38 vs. 17, P = 0.002). Lowest desaturation and mean nocturnal oxygen saturation were significantly lower in subjects with IR (76% vs. 85%, P = 0.004 and 90.4% vs. 93.0%, P = 0.02). In multivariate analysis, the percent of time below 90% saturation [%T < 90]) (P = 0.04) was independently associated with IR. Conclusions: Our results suggested that metabolic syndrome prevalence increased with severity of OSAHS and vice versa. Nocturnal hypoxic episodes in OSAHS patients could be a risk factor for developing hypertension and IR.
- 6 July 2010
- Published by Springer Nature in Sleep and Breathing
- Vol. 15 (3) , 295-300
Influence of snoring on microalbuminuria in diabetic patients
Objective Obstructive sleep apnea (OSA) and snoring are known independent risk factors for insulin resistance. Microalbuminuria is an early marker of diabetic nephropathy and an independent risk factor for cardiovascular disease. The aim of our study was to search the prevalence of self-reported snoring and high-risk pre-test OSA diagnosis in diabetic patients and search the influence of snoring on microalbuminuria. Methods A total of 237 diabetic patients (mean age, 58.6 ± 12.4 years; 126 males), were asked to complete the Berlin Questionnaire that includes questions about snoring, witnessed apnea, tiredness, history of high blood pressure and/or BMI < 30 kg/m2. Also, their past and current medical records were reviewed for their medications, diabetic control, and complications like neuropathy, retinopathy, and microalbuminuria. Results According to the Berlin Questionnaire, a high pre-test probability for the diagnosis of OSA was found in 47.3% of the patients. Snoring was detected in 60.3% of the patients. The mean Epworth Sleepiness Scale score was 7.8 ± 4.6 and 31.6% of the patients reported excessive daytime sleepiness. We found that the both BMI and waist circumferences were significantly associated with snoring and high-risk pre-test OSA. There were no differences for age, gender, fasting glucose, HbA1c, and lipid panels between snorers and non-snorers, and between high-risk pre-test OSA and low-risk pre-test OSA patients. Microalbuminuria was significantly more common in patients who snore. Although snoring was independently associated with microalbuminuria, there were no differences between groups for other microvascular diabetic complications. Conclusion Prevalence of OSA-related symptoms was very common in diabetic patients and further prospective studies are needed to elucidate the role of OSA’s effect on diabetic control and complications.
- 6 July 2010
- Published by Springer Nature in Sleep and Breathing
- Vol. 15 (3) , 295-300
Influence of snoring on microalbuminuria in diabetic patients
Objective Obstructive sleep apnea (OSA) and snoring are known independent risk factors for insulin resistance. Microalbuminuria is an early marker of diabetic nephropathy and an independent risk factor for cardiovascular disease. The aim of our study was to search the prevalence of self-reported snoring and high-risk pre-test OSA diagnosis in diabetic patients and search the influence of snoring on microalbuminuria. Methods A total of 237 diabetic patients (mean age, 58.6 ± 12.4 years; 126 males), were asked to complete the Berlin Questionnaire that includes questions about snoring, witnessed apnea, tiredness, history of high blood pressure and/or BMI < 30 kg/m2. Also, their past and current medical records were reviewed for their medications, diabetic control, and complications like neuropathy, retinopathy, and microalbuminuria. Results According to the Berlin Questionnaire, a high pre-test probability for the diagnosis of OSA was found in 47.3% of the patients. Snoring was detected in 60.3% of the patients. The mean Epworth Sleepiness Scale score was 7.8 ± 4.6 and 31.6% of the patients reported excessive daytime sleepiness. We found that the both BMI and waist circumferences were significantly associated with snoring and high-risk pre-test OSA. There were no differences for age, gender, fasting glucose, HbA1c, and lipid panels between snorers and non-snorers, and between high-risk pre-test OSA and low-risk pre-test OSA patients. Microalbuminuria was significantly more common in patients who snore. Although snoring was independently associated with microalbuminuria, there were no differences between groups for other microvascular diabetic complications. Conclusion Prevalence of OSA-related symptoms was very common in diabetic patients and further prospective studies are needed to elucidate the role of OSA’s effect on diabetic control and complications.